Fig. 4From: Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatmentDrug release profiles of SLN-BUD-2L. (A) Cumulative BUD release curves of SLN-BUD-2L in SGF, SIF, and SCF. (B) Cumulative BUD release curves of SLN-BUD-2L in different simulated fluids over time. (C) Cumulative BUD release profiles of SLN-BUD-2L in LILF and SILF. (D) Cellulase activity in LILF and SILF.Back to article page